Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults
Abstract This 9-month randomised, parallel, double-blind, single-centre, placebo-controlled study (PROBE, ISRCTN18030882) assessed the impact of probiotic supplementation on bodyweight. Seventy overweight Bulgarian participants aged 45–65 years with BMI 25–29.9 kg/m2 received a daily dose of the Lab...
Main Authors: | D. R. Michael, T. S. Davies, A. A. Jack, G. Masetti, J. R. Marchesi, D. Wang, B. H. Mullish, S. F. Plummer |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-78285-3 |
Similar Items
-
Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?
by: Benjamin H. Mullish, et al.
Published: (2021-01-01) -
The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice
by: D. R. Michael, et al.
Published: (2017-06-01) -
Development of a probiotic consortium for people with cancer
by: A. D. Vesnina, et al.
Published: (2021-06-01) -
Creation of the Probiotic Consortium on the Base of Strains of Bifidobacterium spp.
by: Kozhakhmetov, S. S., et al.
Published: (2009-01-01) -
Antioxidant activity of the probiotic consortium in vitro
by: Saule Saduakhasova, et al.
Published: (2014-01-01)